Last price paid | n.a. | |
Change | -44.00% [ -0.11 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | n.a. n.a. |
Fixing | n.a. |
Settlement date | 13.11.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | -77.05% |
Year to date (YTD) | -78.79% |
1 month | -65.85% |
3 months | -68.89% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.61 |
Underlying price on issue | 240.20 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281040332 |
Symbol | IRORXZ |
Security | 128104033 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Roche Hldg G, CH0012032048 |
Underlying ISIN | CH0012032048 |
Funding level | 208.685900 |
Stop-loss level | 214.946500 |
Distance to stop-loss level | 0.40% |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 09.11.2023 |
Premium | 0.74% |
Premium p.a. | n.a. |
Leverage | 30.59 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 5.414100 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Redemption date | 10.05.2024 |
Redemption amount | 0.1252 |
Name | Price |
---|---|
Partners Group Ho... | 1'154.00 |
SWISSCOM N | 505.50 |
NOVARTIS N | 96.17 |
Lonza Group | 490.40 |
SONOVA HLDG N | 277.60 |
Name | Price |
---|---|
Givaudan | 4'260.00 |
Compagnie Financi... | 140.25 |
GEBERIT N | 530.80 |
Sika AG | 257.20 |
Nestlé SA | 91.72 |